Gilead Sciences shares soar after remdesivir drug shows promise against Covid-19

The biotech company’s shares are soaring in pre-market trading on Friday, after its drug remdesivir shows promise in treatment of Covid-19.

Gilead Sciences shares are soaring, up 16% in pre-market trading, with investors optimistic about the stock after its drug remdesivir has shown promise in treating patients with Covid-19.

In a report by Stat News, it mentioned how early impressions from a study at the University of Chicago Medicine showed that almost all severely ill patients treated with the drug rapidly recovered.

‘The best news is that most of our patients have already been discharged, which is great. We’ve only had two patients perish,’ Kathleen Mullane, an infectious disease specialist who is leading the clinical trials at the university hospital in Chicago, said in a video presentation.

Gilead Sciences closed on Thursday at $76 a share, with the stock trading at $89 in pre-market trading as of 12:10 (GMT) on Friday.

It is worth noting that recent clinical trials offer a limited account of the drug’s effectiveness in combating the virus, with similar trials being run at other institutions. Nevertheless, the results offer a glimmer of hope for investors.

‘What we can say at this stage is that we look forward to data from ongoing studies becoming available,’ Gilead Sciences said in a statement.

Mullane, despite her optimism about the early impressions from the study, admitted that it is still too soon to draw too many conclusions about the efficacy of the drug.

‘But certainly when we start [the] drug, we see fever curves falling,’ she said. ‘Fever is now not a requirement for people to go on trial, we do see when patients do come in with high fevers, they do [reduce] quite quickly.’

‘We have seen people come off ventilators a day after starting therapy. So, in that realm, overall our patients have done very well,’ she added.

Wall Street to open higher after success of new drug

Not only is Gilead Sciences shares expected to trade higher on Friday, but the broader market is on track for a higher opening too, as the prospect of a treatment for coronavirus that could help the global economy recover sooner served to boost investor sentiment.

In fact, S&P 500 futures are up more than 3% on Friday, supported by a rally in Asian stocks. Meanwhile, the FTSE 100 and the European Stoxx 600 index are both up 3%.

How to trade stocks with IG

Looking to trade Gilead Sciences and other stocks? Open a live or demo account with IG and buy (long) or sell (short) the asset using derivatives like CFDs and spread bets in a few easy steps:

  • Create an IG Trading Account or log in to your existing account

  • Enter ‘Gilead Sciences’ in the search bar and select it

  • Choose your position size

  • Click on ‘buy’ or ‘sell’ in the deal ticket

  • Confirm the trade

This information has been prepared by IG, a trading name of IG Markets Limited. In addition to the disclaimer below, the material on this page does not contain a record of our trading prices, or an offer of, or solicitation for, a transaction in any financial instrument. IG accepts no responsibility for any use that may be made of these comments and for any consequences that result. No representation or warranty is given as to the accuracy or completeness of this information. Consequently any person acting on it does so entirely at their own risk. Any research provided does not have regard to the specific investment objectives, financial situation and needs of any specific person who may receive it. It has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such is considered to be a marketing communication. Although we are not specifically constrained from dealing ahead of our recommendations we do not seek to take advantage of them before they are provided to our clients. See full non-independent research disclaimer and quarterly summary.

React to global volatility

Market volatility continues as coronavirus concerns amplify. Trade with IG and take advantage of:

  • Tight spreads – from just 1 point on major indices, and 2.8 on US crude
  • Guaranteed stops – they’re free to use, and only incur a fee when triggered
  • Round-the-clock assistance – our highly skilled team are available when you need support

Live prices on most popular markets

  • Forex
  • Shares
  • Indices
Sell
Buy
-
-
-
-
-
-
-
-
-
-
Sell
Buy
Sell
Buy
-
-
China 300
-
-

Prices above are subject to our website terms and agreements. Prices are indicative only. All shares prices are delayed by at least 15 mins.

Plan your trading week

Get the week’s market-moving news sent directly to your inbox every Sunday. The Week Ahead gives you a full calendar of upcoming economic events, as well as commentary from our expert analysts on the key markets to watch.


For more info on how we might use your data, see our privacy notice and access policy and privacy webpage.

You might be interested in…

Find out what charges your trades could incur with our transparent fee structure.

Discover why so many clients choose us, and what makes us a world-leading provider of spread betting and CFDs.

Stay on top of upcoming market-moving events with our customisable economic calendar.

Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 76% of retail investor accounts lose money when trading spread bets and CFDs with this provider. You should consider whether you understand how spread bets and CFDs work, and whether you can afford to take the high risk of losing your money. Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage.